Wegovy may lower risk of cardiovascular threat, drugmaker’s study shows

preview_player
Показать описание
A new study from Novo Nordisk has found that its weight loss drug Wegovy may lower the risk of cardiovascular threat in overweight or obese individuals. NBC News’ Anne Thompson meets with Lester Holt to discuss this finding.

Connect with NBC News Online!

#NBCNews #Wegovy #Cardiovascular
  1. NBC News
  2. Health
  3. International News
  4. Lester Holt
  5. Making A Difference
  6. NBC Nightly News
Рекомендации по теме
Wegovy may lower 0:01:24

Wegovy may lower risk of cardiovascular threat, drugmaker’s study shows

CBS Evening News 0:00:26

CBS Evening News | Study Shows Wegovy May Reduce Risk of Heart Failure

Weight loss drugs 0:03:15

Weight loss drugs like Ozempic may lower cancer risk, study finds

Study finds some 0:00:26

Study finds some weight loss drugs may reduce dementia risk in older adults with diabetes

Weight loss drug 0:00:39

Weight loss drug Wegovy may reduce risk of heart attack

Wegovy to reduce 0:02:03

Wegovy to reduce cardiovascular risks

New study finds 0:03:27

New study finds Wegovy may reduce risk of death from COVID-19

Semaglutide drugs may 0:01:52

Semaglutide drugs may lower risk of opioid overdose: Study

Ozempic (& Wegovy) 0:11:38

Ozempic (& Wegovy) Side Effects | How They Work, What They Do, And Why They Cause Issues

Wegovy and Ozempic 0:02:02

Wegovy and Ozempic could lower heart attack risk

Does Wegovy reduce 0:00:49

Does Wegovy reduce heart attack risk?

Wegovy shown to 0:01:11

Wegovy shown to reduce the risk of heart attacks by 20-25%

Health News 18: 0:00:40

Health News 18: Weight Loss Drugs Could Lower Cancer Risk

Doctors explain how 0:03:29

Doctors explain how Wegovy and Ozempic work | 60 Minutes

New study suggest 0:02:36

New study suggest weight loss drugs may help lower risk of certain cancers

Ozempic and Wegovy: 0:10:44

Ozempic and Wegovy: 5 Common Mistakes to Avoid

Wegovy found to 0:02:02

Wegovy found to reduce risk of serious heart problems | Health Smart

Weight loss drug 0:02:15

Weight loss drug Wegovy can reduce heart attack risk, study says

Doctor Explains EXACTLY 0:03:48

Doctor Explains EXACTLY How Ozempic / Wegovy work...

Does Semaglutide Reduce 0:00:42

Does Semaglutide Reduce Cardiovascular Risk?

Novo Nordisk's Wegovy 0:02:11

Novo Nordisk's Wegovy could reduce heart risks by 20%

Ozempic is a 0:07:12

Ozempic is a game-changer. Here’s how it works.

Weight loss drug 0:00:37

Weight loss drug linked to lower cancer risk

Warning about potential 0:01:51

Warning about potential health risks of weight loss drugs

Комментарии
Автор

TLDR: The weight loss drug Wegovy may lower the risk of strokes and heart attacks by 20% in adults with cardiovascular disease and overweight or obesity, but it is expensive and not yet covered by insurance.

00:00 📉 Wegovy may lower cardiovascular risk, according to drugmaker's study.
00:10 🚨 Wegovy, a popular weight loss drug, may also lower the risk of other serious health threats.
00:19 📉 Study finds that weight loss drug Wegovy not only helps people lose pounds, but also reduces their risk of strokes and heart attacks by 20%.
00:32 📊 A clinical trial of over 17, 000 adults with cardiovascular disease and overweight or obesity showed positive results for Wegovy.
00:42 💊 Wegovy may lower cardiovascular risk, but findings have not been peer reviewed and it's an expensive drug.
00:49 👍 Insurance does not yet cover the drug Wegovy, which can cost up to $1300 a month, but the largest association of health insurers finds the results potentially encouraging.

TheEasyDoc